{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T14:33:48Z","timestamp":1784298828761,"version":"3.55.0"},"reference-count":59,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000097","name":"National Center for Research Resources","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000097","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Psychoneuroendocrinology"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.psyneuen.2019.104471","type":"journal-article","created":{"date-parts":[[2019,10,4]],"date-time":"2019-10-04T11:05:57Z","timestamp":1570187157000},"page":"104471","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":51,"special_numbering":"C","title":["Impact of circadian rhythmicity and sleep restriction on circulating endocannabinoid (eCB) N-arachidonoylethanolamine (anandamide)"],"prefix":"10.1016","volume":"111","author":[{"given":"Erin C.","family":"Hanlon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.psyneuen.2019.104471_bib0005","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18091844","article-title":"Daytime-dependent changes of cannabinoid receptor type 1 and type 2 expression in rat liver","volume":"18","author":"Bazwinsky-Wutschke","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.psyneuen.2019.104471_bib0010","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.3945\/ajcn.2009.28523","article-title":"Acute partial sleep deprivation increases food intake in healthy men","volume":"91","author":"Brondel","year":"2010","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.psyneuen.2019.104471_bib0015","doi-asserted-by":"crossref","first-page":"e3","DOI":"10.1017\/S1462399409000957","article-title":"Emerging role of the cannabinoid receptor CB2 in immune regulation: therapeutic prospects for neuroinflammation","volume":"11","author":"Cabral","year":"2009","journal-title":"Expert Rev. Mol. Med."},{"key":"10.1016\/j.psyneuen.2019.104471_bib0020","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.psyneuen.2016.09.014","article-title":"Sleep restriction alters plasma endocannabinoids concentrations before but not after exercise in humans","volume":"74","author":"Cedernaes","year":"2016","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.psyneuen.2019.104471_bib0025","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/B978-0-12-407766-9.00014-6","article-title":"Endocannabinoids and obesity","volume":"91","author":"Chen","year":"2013","journal-title":"Vitam. Horm."},{"key":"10.1016\/j.psyneuen.2019.104471_bib0030","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1080\/01621459.1979.10481038","article-title":"Robust locally weighted regression and smoothing scatterplots","volume":"74","author":"Cleveland","year":"1979","journal-title":"J. Am. Stat. Assoc."},{"key":"10.1016\/j.psyneuen.2019.104471_bib0035","doi-asserted-by":"crossref","first-page":"271","DOI":"10.3389\/fnins.2018.00271","article-title":"Hedonic eating and the \u201cdelicious circle\u201d: from lipid-derived mediators to brain dopamine and back","volume":"12","author":"Coccurello","year":"2018","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.psyneuen.2019.104471_bib0040","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1056\/NEJMoa044537","article-title":"Effects of rimonabant on metabolic risk factors in overweight patients with dyslipidemia","volume":"353","author":"Despres","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.psyneuen.2019.104471_bib0045","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1126\/science.1470919","article-title":"Isolation and structure of a brain constituent that binds to the cannabinoid receptor","volume":"258","author":"Devane","year":"1992","journal-title":"Science"},{"key":"10.1016\/j.psyneuen.2019.104471_bib0050","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1046\/j.1432-1327.1999.00631.x","article-title":"Biosynthesis and inactivation of the endocannabinoid 2-arachidonoylglycerol in circulating and tumoral macrophages","volume":"264","author":"Di Marzo","year":"1999","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.psyneuen.2019.104471_bib0055","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1124\/jpet.106.118737","article-title":"Antiobesity efficacy of a novel cannabinoid-1 receptor inverse agonist, N-[(1S,2S)-3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl]-2-methyl-2-[[5-(t rifluoromethyl)pyridin-2-yl]oxy]propanamide (MK-0364), in rodents","volume":"321","author":"Fong","year":"2007","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.psyneuen.2019.104471_bib0060","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1021\/ja01062a046","article-title":"Isolation, structure, and partial synthesis of an active constituent of hashish","volume":"86","author":"Gaoni","year":"1964","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.psyneuen.2019.104471_bib0065","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1038\/ijo.2011.165","article-title":"Simultaneous postprandial deregulation of the orexigenic endocannabinoid anandamide and the anorexigenic peptide YY in obesity","volume":"36","author":"Gatta-Cherifi","year":"2012","journal-title":"Int. J. Obes. (Lond.)"},{"issue":"Pt 1","key":"10.1016\/j.psyneuen.2019.104471_bib0070","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1042\/bj2790129","article-title":"Molecular cloning of a human cannabinoid receptor which is also expressed in testis","volume":"279","author":"Gerard","year":"1991","journal-title":"Biochem. J."},{"key":"10.1016\/j.psyneuen.2019.104471_bib0075","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1210\/jc.2014-3455","article-title":"Circadian rhythm of circulating levels of the endocannabinoid 2-arachidonoylglycerol","volume":"100","author":"Hanlon","year":"2015","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.psyneuen.2019.104471_bib0080","doi-asserted-by":"crossref","first-page":"653","DOI":"10.5665\/sleep.5546","article-title":"Sleep restriction enhances the daily rhythm of circulating levels of endocannabinoid 2-arachidonoylglycerol","volume":"39","author":"Hanlon","year":"2016","journal-title":"Sleep"},{"key":"10.1016\/j.psyneuen.2019.104471_bib0085","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1055\/s-2007-993211","article-title":"Serum endocannabinoid content is altered in females with depressive disorders: a preliminary report","volume":"41","author":"Hill","year":"2008","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.psyneuen.2019.104471_bib0090","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.smim.2014.04.001","article-title":"Stress regulates endocannabinoid-CB1 receptor signaling","volume":"26","author":"Hillard","year":"2014","journal-title":"Semin. Immunol."},{"key":"10.1016\/j.psyneuen.2019.104471_bib0095","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/npp.2017.130","article-title":"Circulating endocannabinoids: from whence do they come and where are they going?","volume":"43","author":"Hillard","year":"2018","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.psyneuen.2019.104471_bib0100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/j.2040-4603.2017.tb00740.x","article-title":"Endocannabinoid signaling and the hypothalamic-pituitary-Adrenal Axis","volume":"7","author":"Hillard","year":"2016","journal-title":"Compr. Physiol."},{"key":"10.1016\/j.psyneuen.2019.104471_bib0105","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.neuroscience.2011.11.020","article-title":"Contributions of endocannabinoid signaling to psychiatric disorders in humans: genetic and biochemical evidence","volume":"204","author":"Hillard","year":"2012","journal-title":"Neuroscience"},{"key":"10.1016\/j.psyneuen.2019.104471_bib0110","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.plipres.2016.02.002","article-title":"Endocannabinoids and endocannabinoid-related mediators: targets, metabolism and role in neurological disorders","volume":"62","author":"Iannotti","year":"2016","journal-title":"Prog. Lipid Res."},{"key":"10.1016\/j.psyneuen.2019.104471_bib0115","series-title":"The AASM Manual for the Scoring of Sleep and Associated Events: Rules, Terminology and Technical Specifications","author":"Iber","year":"2007"},{"key":"10.1016\/j.psyneuen.2019.104471_bib0120","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1096\/fj.04-3177fje","article-title":"The CB1 receptor antagonist rimonabant reverses the diet-induced obesity phenotype through the regulation of lipolysis and energy balance","volume":"19","author":"Jbilo","year":"2005","journal-title":"FASEB J."},{"key":"10.1016\/j.psyneuen.2019.104471_bib0125","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1113\/jphysiol.2010.197517","article-title":"Energy expenditure during sleep, sleep deprivation and sleep following sleep deprivation in adult humans","volume":"589","author":"Jung","year":"2011","journal-title":"J. Physiol."},{"key":"10.1016\/j.psyneuen.2019.104471_bib0130","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1096\/fj.201500132","article-title":"Oleoylethanolamine and palmitoylethanolamine modulate intestinal permeability in vitro via TRPV1 and PPARalpha","volume":"31","author":"Karwad","year":"2017","journal-title":"FASEB J."},{"key":"10.1016\/j.psyneuen.2019.104471_bib0135","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1111\/j.1463-1326.2009.01188.x","article-title":"A one-year study to assess the safety and efficacy of the CB1R inverse agonist taranabant in overweight and obese patients with type 2 diabetes","volume":"12","author":"Kipnes","year":"2010","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.psyneuen.2019.104471_bib0140","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s00702-008-0169-6","article-title":"Sleep deprivation increases oleoylethanolamide in human cerebrospinal fluid","volume":"116","author":"Koethe","year":"2009","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.psyneuen.2019.104471_bib0145","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1007\/s00216-010-4103-z","article-title":"Simultaneous measurement of three N-acylethanolamides in human bio-matrices using ultra performance liquid chromatography-tandem mass spectrometry","volume":"398","author":"Lam","year":"2010","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.psyneuen.2019.104471_bib0150","doi-asserted-by":"crossref","first-page":"5695","DOI":"10.1073\/pnas.1216951110","article-title":"Impact of insufficient sleep on total daily energy expenditure, food intake, and weight gain","volume":"110","author":"Markwald","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.psyneuen.2019.104471_bib0155","doi-asserted-by":"crossref","first-page":"23341","DOI":"10.3390\/ijms141223341","article-title":"Does the neuroprotective role of anandamide display diurnal variations?","volume":"14","author":"Martinez-Vargas","year":"2013","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.psyneuen.2019.104471_bib0160","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0306-4522(02)00820-5","article-title":"Sleep modulates cannabinoid receptor 1 expression in the pons of rats","volume":"117","author":"Martinez-Vargas","year":"2003","journal-title":"Neuroscience"},{"key":"10.1016\/j.psyneuen.2019.104471_bib0165","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.tem.2015.07.007","article-title":"The endocannabinoid system: pivotal orchestrator of obesity and metabolic disease","volume":"26","author":"Mazier","year":"2015","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.psyneuen.2019.104471_bib0170","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/0006-2952(95)00109-D","article-title":"Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors","volume":"50","author":"Mechoulam","year":"1995","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.psyneuen.2019.104471_bib0175","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/365061a0","article-title":"Molecular characterization of a peripheral receptor for cannabinoids","volume":"365","author":"Munro","year":"1993","journal-title":"Nature"},{"key":"10.1016\/j.psyneuen.2019.104471_bib0180","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.lfs.2005.12.028","article-title":"Diurnal variation of arachidonoylethanolamine, palmitoylethanolamide and oleoylethanolamide in the brain of the rat","volume":"79","author":"Murillo-Rodriguez","year":"2006","journal-title":"Life Sci."},{"key":"10.1016\/j.psyneuen.2019.104471_bib0185","doi-asserted-by":"crossref","first-page":"126","DOI":"10.3945\/ajcn.2008.26574","article-title":"Sleep curtailment is accompanied by increased intake of calories from snacks","volume":"89","author":"Nedeltcheva","year":"2009","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.psyneuen.2019.104471_bib0190","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1194\/jlr.M400377-JLR200","article-title":"The postmortal accumulation of brain N-arachidonylethanolamine (anandamide) is dependent upon fatty acid amide hydrolase activity","volume":"46","author":"Patel","year":"2005","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.psyneuen.2019.104471_bib0195","doi-asserted-by":"crossref","first-page":"3791","DOI":"10.1097\/00001756-200112040-00038","article-title":"Delta9 -tetrahydrocannabinol increases brain temperature and inverts circadian rhythms","volume":"12","author":"Perron","year":"2001","journal-title":"Neuroreport"},{"key":"10.1016\/j.psyneuen.2019.104471_bib0200","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/j.1463-1326.2004.00374.x","article-title":"The anti-obesity effect of rimonabant is associated with an improved serum lipid profile","volume":"7","author":"Poirier","year":"2005","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.psyneuen.2019.104471_bib0205","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1038\/ijo.2010.38","article-title":"A clinical trial assessing the safety and efficacy of the CB1R inverse agonist taranabant in obese and overweight patients: low-dose study","volume":"34","author":"Proietto","year":"2010","journal-title":"Int. J. Obes. (Lond.)"},{"key":"10.1016\/j.psyneuen.2019.104471_bib0210","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.neubiorev.2016.10.005","article-title":"Endocannabinoids and sleep","volume":"71","author":"Prospero-Garcia","year":"2016","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.psyneuen.2019.104471_bib0215","doi-asserted-by":"crossref","first-page":"R345","DOI":"10.1152\/ajpregu.00545.2002","article-title":"Anti-obesity effect of SR141716, a CB1 receptor antagonist, in diet-induced obese mice","volume":"284","author":"Ravinet Trillou","year":"2003","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"10.1016\/j.psyneuen.2019.104471_bib0220","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1007\/s00213-007-0911-z","article-title":"A potential function of endocannabinoids in the selection of a navigation strategy by rats","volume":"198","author":"Rueda-Orozco","year":"2008","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.psyneuen.2019.104471_bib0225","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1080\/03610919508813281","article-title":"An expanded table of probability values for rao\u2019s spacing test","volume":"24","author":"Russell","year":"1995","journal-title":"Commun. Stat. - Simul. Comput."},{"key":"10.1016\/j.psyneuen.2019.104471_bib0230","doi-asserted-by":"crossref","first-page":"432607","DOI":"10.1155\/2011\/432607","article-title":"Rimonabant: from RIO to ban","volume":"2011","author":"Sam","year":"2011","journal-title":"J. Obes."},{"key":"10.1016\/j.psyneuen.2019.104471_bib0235","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1016\/S0140-6736(06)69571-8","article-title":"Efficacy and tolerability of rimonabant in overweight or obese patients with type 2 diabetes: a randomised controlled study","volume":"368","author":"Scheen","year":"2006","journal-title":"Lancet"},{"issue":"Suppl. 1","key":"10.1016\/j.psyneuen.2019.104471_bib0240","first-page":"5","article-title":"Predicting basal metabolic rate, new standards and review of previous work","volume":"39","author":"Schofield","year":"1985","journal-title":"Hum. Nutr. Clin. Nutr."},{"key":"10.1016\/j.psyneuen.2019.104471_bib0245","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.3945\/ajcn.113.069427","article-title":"Experimental sleep curtailment causes wake-dependent increases in 24-h energy expenditure as measured by whole-room indirect calorimetry","volume":"98","author":"Shechter","year":"2013","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.psyneuen.2019.104471_bib0250","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1002\/eji.201546181","article-title":"Production of endocannabinoids by activated T cells and B cells modulates inflammation associated with delayed-type hypersensitivity","volume":"46","author":"Sido","year":"2016","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.psyneuen.2019.104471_bib0255","doi-asserted-by":"crossref","first-page":"846","DOI":"10.7326\/0003-4819-141-11-200412070-00008","article-title":"Brief communication: sleep curtailment in healthy young men is associated with decreased leptin levels, elevated ghrelin levels, and increased hunger and appetite","volume":"141","author":"Spiegel","year":"2004","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.psyneuen.2019.104471_bib0260","doi-asserted-by":"crossref","first-page":"410","DOI":"10.3945\/ajcn.111.013904","article-title":"Short sleep duration increases energy intakes but does not change energy expenditure in normal-weight individuals","volume":"94","author":"St-Onge","year":"2011","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.psyneuen.2019.104471_bib0265","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1006\/bbrc.1995.2437","article-title":"2-Arachidonoylglycerol: a possible endogenous cannabinoid receptor ligand in brain","volume":"215","author":"Sugiura","year":"1995","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.psyneuen.2019.104471_bib0270","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1189\/jlb.3RU0115-021R","article-title":"Regulation of inflammation by cannabinoids, the endocannabinoids 2-arachidonoyl-glycerol and arachidonoyl-ethanolamide, and their metabolites","volume":"97","author":"Turcotte","year":"2015","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.psyneuen.2019.104471_bib0275","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1007\/s00018-003-3453-5","article-title":"Differential diurnal variations of anandamide and 2-arachidonoyl-glycerol levels in rat brain","volume":"61","author":"Valenti","year":"2004","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.psyneuen.2019.104471_bib0280","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1016\/S0140-6736(05)66374-X","article-title":"Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients: 1-year experience from the RIO-Europe study","volume":"365","author":"Van Gaal","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.psyneuen.2019.104471_bib0285","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1093\/eurheartj\/ehn076","article-title":"Long-term effect of CB1 blockade with rimonabant on cardiometabolic risk factors: two year results from the RIO-Europe Study","volume":"29","author":"Van Gaal","year":"2008","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.psyneuen.2019.104471_bib0290","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1111\/j.1476-5381.2010.00790.x","article-title":"Endocannabinoid signalling: has it got rhythm?","volume":"160","author":"Vaughn","year":"2010","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.psyneuen.2019.104471_bib0295","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/npp.2017.126","article-title":"Endocannabinoid regulation of reward and reinforcement through interaction with dopamine and endogenous opioid signaling","volume":"43","author":"Wenzel","year":"2018","journal-title":"Neuropsychopharmacology"}],"container-title":["Psychoneuroendocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306453019310200?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306453019310200?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T15:28:20Z","timestamp":1778686100000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306453019310200"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":59,"alternative-id":["S0306453019310200"],"URL":"https:\/\/doi.org\/10.1016\/j.psyneuen.2019.104471","relation":{},"ISSN":["0306-4530"],"issn-type":[{"value":"0306-4530","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of circadian rhythmicity and sleep restriction on circulating endocannabinoid (eCB) N-arachidonoylethanolamine (anandamide)","name":"articletitle","label":"Article Title"},{"value":"Psychoneuroendocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.psyneuen.2019.104471","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"104471"}}